NP / PA
Vienne, Lezette
Vienne, Lezette was paid $26K by Medicaid between Dec 2022 and Jan 2023, across 8 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 39% of everything it billed.
33Billing provider infoVIENNE, LEZETTE
LAFAYETTE, LA 70506
LAFAYETTE, LA 70506
33aNPI1003249640assigned 08/19/2013
33bProvider typeNurse Practitioner
28Total paid$26K
24GClaims397
24DCodes billed8
24AFirst – last monthDec 2022 – Jan 2023
Compared with peers
Next to other Nurse Practitioner providers in Louisiana
Rank by total paid#27 of 62
Median peer was paid$13K
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 294 | $13K | |
| 2023 | 103 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 39% | 24 | 24 | $10K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 173 | 161 | $7K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 16% | 38 | 34 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 64 | 58 | $3K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 12 | 12 | $684.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 46 | 23 | $535.12 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.6% | 13 | 13 | $413.80 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 27 | 25 | $262.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.